HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Drug Use Addiction
Drug Use Addiction
It is also known as substance use disorder, and it occurs when a person's behaviour and brain are damaged, resulting in an inability to manage their use of a legal or illegal drug or treatment. Marijuana, alcohol, and nicotine are all examples of drugs that people abuse. Addicts are unable to distinguish between the harmful consequences of using these drugs. Drug addiction can affect people of any age, gender, or socioeconomic level. Factors that can influence the likelihood and pace with which an addiction develops:
- Family history of addiction
- Mental health disorder
- Peer pressure
- Lack of family involvement
- Early use
- Taking a highly addictive drug
Committee Members
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States GAB 2026 Speakers
John Michael Weber
Trauma Healed Life Coach, United States
Denis Larrivee
University of Navarra, Spain
Steve Cohen
Medvesta Hypnosis Healthcare, United States
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : Beating the blues today
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States